Arnaud Uguen

2.7k total citations
98 papers, 1.7k citations indexed

About

Arnaud Uguen is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Arnaud Uguen has authored 98 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 30 papers in Molecular Biology and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Arnaud Uguen's work include Cancer Genomics and Diagnostics (18 papers), Lung Cancer Treatments and Mutations (15 papers) and Melanoma and MAPK Pathways (13 papers). Arnaud Uguen is often cited by papers focused on Cancer Genomics and Diagnostics (18 papers), Lung Cancer Treatments and Mutations (15 papers) and Melanoma and MAPK Pathways (13 papers). Arnaud Uguen collaborates with scholars based in France, United States and Italy. Arnaud Uguen's co-authors include Pascale Marcorelles, Marc De Braekeleer, Matthieu Talagas, Guillaume Demey, Florent Weppe, Robert A. Magnussen, Maad F. AlSaati, Jean-Philippe Vincent, Philippe Neyret and Elvire Servıen and has published in prestigious journals such as PLoS ONE, Oncogene and Annals of Neurology.

In The Last Decade

Arnaud Uguen

91 papers receiving 1.7k citations

Peers

Countries citing papers authored by Arnaud Uguen

Since Specialization

Citations

This map shows the geographic impact of Arnaud Uguen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnaud Uguen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnaud Uguen more than expected).

Fields of papers citing papers by Arnaud Uguen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnaud Uguen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnaud Uguen. The network helps show where Arnaud Uguen may publish in the future.

Co-authorship network of co-authors of Arnaud Uguen

This figure shows the co-authorship network connecting the top 25 collaborators of Arnaud Uguen. A scholar is included among the top collaborators of Arnaud Uguen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnaud Uguen. Arnaud Uguen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Automated classification of tertiary lymphoid structures in colorectal cancer using TLS-PAT artificial intelligence tool 2025 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Arnaud Uguen	1
2	MHC class II: a predictor of outcome in melanoma treated with immune checkpoint inhibitors 2025 ·Melanoma Research ·Karim Amrane, (unknown), Patrice Hémon, Ronan Abgral, (unknown), Olivier Pradier, L. Misery, Délphine Legoupil, Christian Berthou, Arnaud Uguen	0
3	Enquête nationale de la Société française de pathologie sur la recherche et l’utilisation de l’intelligence artificielle (IA) appliquée à la pathologie 2024 ·Annales de Pathologie ·(unknown), (unknown), Arnaud Uguen, Thierry Pécot, Sophie Prévôt, Catherine Guettier, Janick Sèlves, Philippe Bertheau, Camille Franchet, Magali Svrcek, Jean‐Christophe Sabourin, Marie Brevet, Julien Caldéraro, Nathalie Rioux‐Leclercq, Delphine Loussouarn, (unknown)	0
4	HLA-DR expression in melanoma: from misleading therapeutic target to potential immunotherapy biomarker 2024 ·Frontiers in Immunology ·Karim Amrane, (unknown), Benjamin Besse, Patrice Hémon, (unknown), Olivier Pradier, Christian Berthou, Ronan Abgral, Arnaud Uguen	14
5	Deciphering the maturation of tertiary lymphoid structures in cancer and inflammatory diseases of the digestive tract using imaging mass cytometry 2023 ·Frontiers in Immunology ·(unknown), Patrice Hémon, (unknown), Soizic Garaud, Christelle Le Dantec, Jacques‐Olivier Pers, Divi Cornec, Arnaud Uguen	21
6	The Histopathological “Placentitis Triad” Is Specific for SARS-CoV-2 Infection, and Its Acute Presentation Can Be Associated with Poor Fetal Outcome 2023 ·Life ·(unknown), (unknown), (unknown), Arnaud Uguen, Pascale Marcorelles, Claire de Moreuil	2
7	Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists? 2023 ·Cancers ·(unknown), Virginie Conan‐Charlet, Isabelle Quintin‐Roué, Laurent Doucet, Pascale Marcorelles, Arnaud Uguen	5
8	Discoidin Domain Receptor 2 orchestrates melanoma resistance combining phenotype switching and proliferation 2022 ·Oncogene ·(unknown), Nathalie Allain, Mélanie Moreau, Arnaud Jabouille, Elodie Henriet, (unknown), Arnaud Uguen, Sylvaine Di-Tommaso, (unknown), Anne‐Aurélie Raymond, Jean‐William Dupuy, E. Gérard, Nathalie Dugot‐Senant, Benoı̂t Rousseau, (unknown), (unknown), B. Vergier, Sophie Tartare‐Deckert, Violaine Moreau, Frédéric Saltel	17
9	Diagnostic mutationnel rapide Idylla™ : applications théranostiques actuelles et futures 2022 ·Annales de Pathologie ·(unknown), (unknown), (unknown), Arnaud Uguen	1
10	71P Searching for predictive biomarkers of efficacy in small cell lung cancer (SCLC) patients treated with chemotherapy-immunotherapy combination using imaging mass cytometry (the HYPE study) 2021 ·Annals of Oncology ·(unknown), Patrice Hémon, (unknown), G. Robinet, R. Descourt, Gilles Quéré, (unknown), (unknown), (unknown), Ulrike Schick, (unknown), Arnaud Uguen, Margaux Geier	4
11	HER2 Mutated and Nonmutated Non–small Cell Lung Carcinomas Can Harbor Heterogeneous HER2 Gene Amplification and HER2 Protein Expression 2020 ·Applied immunohistochemistry & molecular morphology ·(unknown), (unknown), Isabelle Quintin‐Roué, Arnaud Uguen	1
12	Small‐fibre neuropathy and pruritus: histological patterns of nerve fibres in skin biopsies 2019 ·British Journal of Dermatology ·(unknown), E. Brenaut, Matthieu Talagas, Arnaud Uguen, Hélène Bonsang‐Kitzis, L. Misery, Pascale Marcorelles	4
13	Histopathological factors help to predict lymph node metastases more efficiently than extra-nodal recurrences in submucosa invading pT1 colorectal cancer 2019 ·Scientific Reports ·(unknown), Mélanie Cariou, Philippe Saliou, (unknown), (unknown), (unknown), (unknown), Bogdan Badic, J Jézéquel, Franck Cholet, Jean-Pierre Bail, Pascale Marcorelles, Jean‐Baptiste Nousbaum, Michel Robaszkiewicz, Laurent Doucet, Arnaud Uguen	25
14	High reproducibility is attainable in assessing histoprognostic parameters of pT1 colorectal cancer using routine histopathology slides and immunohistochemistry analyses 2018 ·Pathology ·(unknown), (unknown), Mélanie Cariou, (unknown), (unknown), (unknown), Bogdan Badic, J Jézéquel, Franck Cholet, Jean-Pierre Bail, Pascale Marcorelles, Jean‐Baptiste Nousbaum, Michel Robaszkiewicz, Laurent Doucet, Arnaud Uguen	19
15	Cosmetic Outcome and Chronic Breast Toxicity After Intraoperative Radiation Therapy (IORT) as a Single Modality or as a Boost Using the Intrabeam® Device: A Prospective Study 2017 ·Annals of Surgical Oncology ·(unknown), (unknown), Pierre‐François Dupré, (unknown), (unknown), Ronan Abgral, Virginie Conan‐Charlet, Arnaud Uguen, Olivier Pradier, Ulrike Schick	28
16	Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancer 2016 ·BMC Cancer ·Gilles Quéré, R. Descourt, G. Robinet, (unknown), Odile Raguénès, (unknown), (unknown), Arnaud Uguen, Claude Férec, Isabelle Quintin‐Roué, Gérald Le Gac	26
17	ROS1 Fusions in Cancer: A Review 2016 ·Future Oncology ·Arnaud Uguen, Marc De Braekeleer	62
18	A p16-Ki-67-HMB45 immunohistochemistry scoring system as an ancillary diagnostic tool in the diagnosis of melanoma 2015 ·Diagnostic Pathology ·Arnaud Uguen, Matthieu Talagas, Sebastian Costa, (unknown), (unknown), Marc De Braekeleer, Pascale Marcorelles	61
19	Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumors 2015 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Arnaud Uguen, (unknown), Laurent Doucet, Matthieu Talagas, Sebastian Costa, Marc De Braekeleer, Pascale Marcorelles	18
20	MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas 2015 ·European Journal of Cancer ·Charles‐Henry Gattolliat, Arnaud Uguen, (unknown), (unknown), Brigitte Simon, Laurent Doucet, M. Robaszkiewicz, Laurent Corcos	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact